Health Condition 1: null- Laproscopic surgeries
Conditions
Interventions
Intervention1: Injection Ondensetron: Single dose of 4mg Ondensetron diluted with normal saline to 4ml intravenous over one minute
Control Intervention1: Injection palonosetron: Single dose of 0.075mg
Sponsors
Shamshuzoha M
Eligibility
Inclusion criteria
Inclusion criteria: Posted for elective Laproscopic surgery under General anesthesia
Exclusion criteria
Exclusion criteria: Patients with presence of infection on the dorsum of non-dominant hand Patients with thin dorsal veins Patients with known hypersensitivity to Propofol, Ondensetron and Palonosetron
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain during injection of Propofol Timepoint: 1, 3 and 5 minute after induction | — |
Secondary
| Measure | Time frame |
|---|---|
| Post operative nausea and vomitingTimepoint: Noted for 24 hours Post operative period | — |
Countries
India
Contacts
Public ContactShamshuzoha M
Kempegowda Insitute of Medical Sciences
Outcome results
None listed